Apria, Inc. (APR): Price and Financial Metrics

Apria, Inc. (APR): $37.50

0.01 (+0.03%)

POWR Rating

Component Grades














  • Quality is the dimension where APR ranks best; there it ranks ahead of 97.93% of US stocks.
  • The strongest trend for APR is in Quality, which has been heading up over the past 178 days.
  • APR's current lowest rank is in the Sentiment metric (where it is better than 9.32% of US stocks).

APR Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for APR is 28.82 -- better than 99.1% of US stocks.
  • Apria Inc's stock had its IPO on February 11, 2021, making it an older stock than merely 0.42% of US equities in our set.
  • APR's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of 99.48% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Apria Inc, a group of peers worth examining would be JWN, UNFI, VOLT, BJ, and PRTY.
  • To check out Apria Inc's SEC filings, go to the company's page on browse-edgar?action=getcompany&CIK=0001735803.

APR Valuation Summary

  • In comparison to the median Healthcare stock, APR's price/sales ratio is 90.31% lower, now standing at 1.1.
  • Over the past 29 weeks, APR's price/sales ratio has gone up 0.3.
  • APR's EV/EBIT ratio has moved down 9.9 over the prior 29 weeks.

Below are key valuation metrics over time for APR.

Stock Date P/S P/B P/E EV/EBIT
APR 2021-08-31 1.1 751.7 27.3 20.9
APR 2021-08-30 1.1 748.1 27.1 20.8
APR 2021-08-27 1.1 760.8 27.6 21.1
APR 2021-08-26 1.1 758.6 27.5 21.1
APR 2021-08-25 1.2 765.8 27.8 21.3
APR 2021-08-24 1.2 765.0 27.7 21.2

APR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • APR has a Quality Grade of B, ranking ahead of 90.05% of graded US stocks.
  • APR's asset turnover comes in at 1.677 -- ranking 5th of 81 Healthcare stocks.
  • 500 - Internal server error

The table below shows APR's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2020-12-31 1.677 0.704 0.134

APR Price Target

For more insight on analysts targets of APR, see our APR price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $34.75 Average Broker Recommendation 1.5 (Moderate Buy)

APR Stock Price Chart Interactive Chart >

Price chart for APR

APR Price/Volume Stats

Current price $37.50 52-week high $40.00
Prev. close $37.49 52-week low $22.36
Day low $37.49 Volume 585,400
Day high $37.51 Avg. volume 682,285
50-day MA $37.33 Dividend yield N/A
200-day MA $33.53 Market Cap 1.34B

Apria, Inc. (APR) Company Bio

Apria, Inc. provides integrated home healthcare equipment and related services in the United States. The company offers home respiratory therapies, including the supply of stationary and portable home oxygen equipment, and non-invasive ventilators; obstructive sleep apnea therapy devices comprising continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services; and negative pressure wound therapy products. It also offers a range of home medical equipment and other products, and services for patients with home care needs; and clinical and administrative support services, and related products and supplies to patients. The company was incorporated in 2018 and is headquartered in Indianapolis, Indiana.

APR Latest News Stream

Event/Time News Detail
Loading, please wait...

APR Latest Social Stream

Loading social stream, please wait...

View Full APR Social Stream

Latest APR News From Around the Web

Below are the latest news stories about Apria Inc that investors may wish to consider to help them evaluate APR as an investment opportunity.

Apria Announces Expiration of Hart-Scott-Rodino Waiting Period

INDIANAPOLIS, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Apria, Inc. (the “Company” or “Apria”) (Nasdaq: APR), a leading provider of home medical equipment, supplies and related services in the United States, announced today that the waiting period has expired under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, in connection with its previously announced transaction with Owens & Minor, Inc. The closing of the transaction remains subject to approval by holders of a majority of the

Yahoo | February 24, 2022

Owens & Minor: Not A Minor Deal

Owens & Minor (OMI) has come to life during the pandemic. In October 2020, I concluded that shares looked a lot healthier, as shares had five-folded on the back of the pandemic. Stagnating sales, non-inspiring margins, and a debt-loaded balance sheet made investors very cautious, as the pandemic came at...

The Value Investor on Seeking Alpha | February 21, 2022

Is Apria (APR) Stock Outpacing Its Medical Peers This Year?

Here is how Apria (APR) and Actinium Pharmaceuticals (ATNM) have performed compared to their sector so far this year.

Yahoo | January 11, 2022

Company News for Jan 11, 2022

Companies in The News Are: CMC,AZZ,ZNGA,TTWO,APR,OMI

Yahoo | January 11, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

Welcome back, trader!

William White on InvestorPlace | January 10, 2022

Read More 'APR' Stories Here

APR Price Returns

1-mo N/A
3-mo N/A
6-mo 15.03%
1-year 36.61%
3-year N/A
5-year N/A
YTD 15.03%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.5498 seconds.